TY  - JOUR
AU  - Palma, Francesco
AU  - Affinito, Alessandra
AU  - Nuzzo, Silvia
AU  - Roscigno, Giuseppina
AU  - Scognamiglio, Iolanda
AU  - Ingenito, Francesco
AU  - Martinez Garcia, Maria Dolores
AU  - Franzese, Monica
AU  - Zanfardino, Mario
AU  - Soricelli, Andrea
AU  - Fiorelli, Alfonso
AU  - Condorelli, Gerolama
AU  - Quintavalle, Cristina
PY  - 2021
DO  - 10.1038/s41417-020-00224-1
UR  - http://hdl.handle.net/20.500.12105/17427
AB  - Lung cancer is still the leading cause of death by cancer worldwide despite advances both in its detection and therapy. Multiple oncogenic driver alterations have been discovered, opening the prospective for new potential therapeutic targets. Among...
LA  - eng
PB  - Nature Publishing Group
KW  - Gene Expression Regulation, Neoplastic
KW  - Synthetic Lethal Mutations
KW  - Adenocarcinoma of Lung
KW  - Apoptosis
KW  - CDC2 Protein Kinase
KW  - Carcinoma, Non-Small-Cell Lung
KW  - Cell Movement
KW  - Cell Proliferation
KW  - Humans
KW  - Lung Neoplasms
KW  - MicroRNAs
KW  - Prognosis
KW  - Prospective Studies
KW  - Proto-Oncogene Proteins p21(ras)
KW  - Survival Rate
KW  - Tumor Cells, Cultured
TI  - miR-34c-3p targets CDK1 a synthetic lethality partner of KRAS in non-small cell lung cancer.
TY  - journal article
ER  -